164 related articles for article (PubMed ID: 31965550)
41. Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons.
Kharkwal G; Brami-Cherrier K; Lizardi-Ortiz JE; Nelson AB; Ramos M; Del Barrio D; Sulzer D; Kreitzer AC; Borrelli E
Neuron; 2016 Jul; 91(1):67-78. PubMed ID: 27387649
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory Pedunculopontine Neurons Gate Dopamine-Mediated Motor Actions of Unsigned Valence.
Zhang S; Mena-Segovia J; Gut NK
Curr Neuropharmacol; 2024; 22(9):1540-1550. PubMed ID: 37702175
[TBL] [Abstract][Full Text] [Related]
43. LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function.
Sloan M; Alegre-Abarrategui J; Potgieter D; Kaufmann AK; Exley R; Deltheil T; Threlfell S; Connor-Robson N; Brimblecombe K; Wallings R; Cioroch M; Bannerman DM; Bolam JP; Magill PJ; Cragg SJ; Dodson PD; Wade-Martins R
Hum Mol Genet; 2016 Mar; 25(5):951-63. PubMed ID: 26744332
[TBL] [Abstract][Full Text] [Related]
44. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.
Richter F; Gao F; Medvedeva V; Lee P; Bove N; Fleming SM; Michaud M; Lemesre V; Patassini S; De La Rosa K; Mulligan CK; Sioshansi PC; Zhu C; Coppola G; Bordet T; Pruss RM; Chesselet MF
Neurobiol Dis; 2014 Sep; 69():263-75. PubMed ID: 24844147
[TBL] [Abstract][Full Text] [Related]
45. Levodopa affects spike and local field synchronisation in the pedunculopontine nucleus of a rat model of Parkinson's disease.
Zhang H; Xie J; Li Y; Liu H; Liu C; Kan D; Geng X; Wei S
Aging (Albany NY); 2021 Feb; 13(5):7314-7329. PubMed ID: 33639616
[TBL] [Abstract][Full Text] [Related]
46. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
[TBL] [Abstract][Full Text] [Related]
47. Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats.
Chambers NE; Coyle M; Sergio J; Lanza K; Saito C; Topping B; Clark SD; Bishop C
Eur J Neurosci; 2021 Apr; 53(8):2835-2847. PubMed ID: 33426708
[TBL] [Abstract][Full Text] [Related]
48. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O
Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207
[TBL] [Abstract][Full Text] [Related]
49. Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M
Moehle MS; Pancani T; Byun N; Yohn SE; Wilson GH; Dickerson JW; Remke DH; Xiang Z; Niswender CM; Wess J; Jones CK; Lindsley CW; Rook JM; Conn PJ
Neuron; 2017 Dec; 96(6):1358-1372.e4. PubMed ID: 29268098
[TBL] [Abstract][Full Text] [Related]
50. Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP-induced Parkinson's disease.
Haga H; Matsuo K; Yabuki Y; Zhang C; Han F; Fukunaga K
Neurochem Int; 2019 Oct; 129():104492. PubMed ID: 31229554
[TBL] [Abstract][Full Text] [Related]
51. A cholinergic input to the substantia nigra pars compacta increases striatal dopamine metabolism measured by in vivo voltammetry.
Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Aceves J
Brain Res; 1992 Dec; 598(1-2):114-20. PubMed ID: 1486473
[TBL] [Abstract][Full Text] [Related]
52. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
[TBL] [Abstract][Full Text] [Related]
53. Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease.
Bury AG; Pyle A; Elson JL; Greaves L; Morris CM; Hudson G; Pienaar IS
Ann Neurol; 2017 Dec; 82(6):1016-1021. PubMed ID: 29149768
[TBL] [Abstract][Full Text] [Related]
54. Nurr1, Pitx3, and α7 nAChRs mRNA Expression in Nigral Tissue of Rats with Pedunculopontine Neurotoxic Lesion.
Blanco-Lezcano L; Alberti-Amador E; González-Fraguela ME; Larrea GZ; Pérez-Serrano RM; Jiménez-Luna NA; Serrano-Sánchez T; Francis-Turner L; Camejo-Rodriguez D; Vega-Hurtado Y
Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31547185
[No Abstract] [Full Text] [Related]
55. Comparing tonic and phasic dendritic calcium in cholinergic pedunculopontine neurons and dopaminergic substantia nigra neurons.
Chen RY; Evans RC
Eur J Neurosci; 2024 Apr; 59(7):1638-1656. PubMed ID: 38383047
[TBL] [Abstract][Full Text] [Related]
56. Effect of globus pallidus internus stimulation on neuronal activity in the pedunculopontine tegmental nucleus in the primate model of Parkinson's disease.
Zhang J; Wang ZI; Baker KB; Vitek JL
Exp Neurol; 2012 Jan; 233(1):575-80. PubMed ID: 21821025
[TBL] [Abstract][Full Text] [Related]
57. Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats.
Korkmaz O; Ay H; Ulupinar E; Tunçel N
J Mol Neurosci; 2012 Nov; 48(3):565-73. PubMed ID: 22544516
[TBL] [Abstract][Full Text] [Related]
58. Protection against dopaminergic nigrostriatal cell death by excitatory input ablation.
Takada M; Matsumura M; Kojima J; Yamaji Y; Inase M; Tokuno H; Nambu A; Imai H
Eur J Neurosci; 2000 May; 12(5):1771-80. PubMed ID: 10792454
[TBL] [Abstract][Full Text] [Related]
59. The anterior and posterior pedunculopontine tegmental nucleus are involved in behavior and neuronal activity of the cuneiform and entopeduncular nuclei.
Jin X; Schwabe K; Krauss JK; Alam M
Neuroscience; 2016 May; 322():39-53. PubMed ID: 26880033
[TBL] [Abstract][Full Text] [Related]
60. Subthalamic nucleus deep brain stimulation induces sustained neurorestoration in the mesolimbic dopaminergic system in a Parkinson's disease model.
Fauser M; Ricken M; Markert F; Weis N; Schmitt O; Gimsa J; Winter C; Badstübner-Meeske K; Storch A
Neurobiol Dis; 2021 Aug; 156():105404. PubMed ID: 34044146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
